Navigation Links
CVS Caremark Corporation Announces Quarterly Dividend
Date:3/4/2009

WOONSOCKET, R.I., March 4 /PRNewswire-FirstCall/ -- CVS Caremark Corporation (NYSE: CVS) today announced that its Board of Directors has approved its quarterly dividend of $0.07625 per share on the Common Stock of the Corporation, payable May 4, 2009 to holders of record on April 22, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO )

About CVS Caremark

CVS Caremark is the largest provider of prescriptions in the nation. The Company fills or manages more than 1 billion prescriptions annually. Through its unmatched breadth of service offerings, CVS Caremark is transforming the delivery of health care services in the U.S. The Company is uniquely positioned to effectively manage costs and improve health care outcomes through its more than 6,900 CVS/pharmacy and Longs Drugs stores; its Caremark Pharmacy Services division (pharmacy benefit management, mail order and specialty pharmacy); its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. General information about CVS Caremark is available through the Investors section of the Company's Web site, at cvscaremark.com, as well as through the Newsroom section of the Company's Web site, at cvscaremark.com/newsroom.


'/>"/>
SOURCE CVS Caremark Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. CVS Caremark Health Management Programs Help Multiple Sclerosis Patients Better Manage Weight Issues and Improve BMI
2. CVS Caremark Corporation to Present at the Raymond James Institutional Investors Conference on March 10th
3. CVS Caremark Reports Record Results in Fourth Quarter and Year 2008
4. CVS Caremark Issues Statement on Settlement Concerning Disposal of Patient Information at its Retail Stores
5. Caremark Customer Care Centers Recognized for Customer Satisfaction Excellence by J.D. Power and Associates Certified Call Center Program(SM)
6. CVS Caremark Presents Influenza Vaccine Data at Rescheduled 2008 DMAA Annual Meeting
7. CVS Caremark Named Finalist in URAC Annual Best Practices in Health Care Consumer Empowerment and Protection Awards
8. CVS Caremark Applauds FTCs Leadership on Follow-on Biologics
9. CVS Caremark All Kids Can Announces the Opening of a Boundless Playground in Los Angeles to Serve Children of All Abilities
10. CVS Caremark Names Troyen Brennan, MD, EVP, Chief Medical Officer
11. SilverScript Insurance Company, a CVS Caremark Company, Provides Variety of Medicare Prescription Drug Plan Options for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
Breaking Medicine Technology: